Ginkgo Bioworks DNA Return on equity

Return on equity at other companies

Thermo Fisher ScientificTMO

13.5%+0.1pp

Charles River LaboratoriesCRL

-7.7%—

AbCellera Biologics Inc.ABCL

-17.3%+2.1pp

eXoZymes, Inc.EXOZ

-185.8%—

TEC

Bio-TechneTECH

6.5%-3.9pp

RevvityRVTY

3.2%-0.5pp

FAQ

What is Ginkgo Bioworks's return on equity?

Ginkgo Bioworks (DNA) reported return on equity of -56.3% in Q2 2026.

How has Ginkgo Bioworks's return on equity changed year-over-year?

Ginkgo Bioworks's return on equity decreased by 29.1% year-over-year, from -43.6% to -56.3%.

What is the long-term trend for Ginkgo Bioworks's return on equity?

Over 5 years (2020 to 2025), Ginkgo Bioworks's return on equity has grown at a 14.1% compound annual growth rate (CAGR), from -26.4% to -51.1%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.